EFFECTS OF PHARMACIST COUNSELING ON COMPLIANCE AND INR SCORE ON OUTPATIENTS RECEIVING WARFARIN AT DR. HASAN SADIKIN BANDUNG HOSPITAL WEST JAVA, INDONESIA
DOI:
https://doi.org/10.22159/ajpcr.2017.v10s2.19492Keywords:
Warfarin, Counseling, Compliance, International normalized ratioAbstract
Objective:Warfarin is a derivate of coumarin, which is usually prescribed as an oral anti-coagulant for treatment and prevention of thromboembolic disorders. The aim of presents research is analysis the influence of pharmacist counseling on complience and INR score recovery on warfarin management.
Methods:Design in this research used mixed method, combination ofqualitative and quantitative method. Qualitative data were used for completingquantitative data. Qualitative method used a content analysis with interview.Quantitative method used a quasi experimental method with control groups, pre test, and post test design. Data were analysed by wilcoxon test and mann whitney test at significance levelP ≤ 0,05 and multivariate analysis covariate.
Results:Data were collected from 80 patients with Rheumatic Heart Disease (42.5 %), Atrial Fibrilation (17.5 %), Deep Vein Thrombosis (10%), Rheumatic Mitral Valve Disease (10%), Prosthetic Heart (7.5%), other (22.5%). The numbers of patients whose International Normalized Ratio (INR) was in the therapeutic range for each indication were not statistically different between before and after receiving counseling (P >0.05), Patients' behavior compliance of warfarin therapy had increased after receiving the counseling service (P <0.05). The result of presents research is pharmacist counseling affected behavior compliance before and after counseling(P <0.05), but not for INR (P >0.05).
Conclusion:Pharmacist counseling can improve behavior compliance, but not improve INR target. The effect of warfarin to every individual not only affected by behavior compliance, but several factors could influence effect of warfarin is clinical factors, non clinical factors, and genetic factors. Clinical factors that wereinfluenced were age, gender, pharmacokinetic and pharmacodynamic variability in patiens.
Â
Downloads
References
Hirsch J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J. Oral anticoagulan: mechanisms of action, clinical effectiveness and optimal therapeutic range. Chest. 2001;119 Suppl 1;8S-21S.
Rose P. Audit of anticoagulant therapy. J Clin Pathol .1996;49 Suppl 1.5:5–9.
Conway DS, Lip G. Atrial fibrillation. Medicine 2002;30:140–4.
N Aliza. Monitoring Therapy Warfarin On Outpatients in Bandung Hospital. Skripsi. 2010
Tang EO, Lai CS, Lee KK, et al. Relationship between patients’ warfarin knowledge and anticoagulation control. Ann Pharmacother. 2003;37 Suppl 1:34–9.
Waterman AD, Milligan PE, Bayer L, et al. Effect of warfarin nonadherence on control of the international normalized ratio. Am J Health- Syst Pharm. 2004;61 Suppl 12:58–64.
Ian A. Orensky, David A. Holdford. Predictors of Noncompliance with Warfarin Therapy
in an Outpatient Anticoagulation Clinic. Pharmacotherapy. 2005;25 Suppl 12:1801–8
Lewis RK, Lasack NL, Lambert BL, Connor SE. Patientcounselling – A focus on maintenance therapy. Am J Health Syst Pharm.1997;54 Suppl 18:2084‑98.
Burge S, White D, Bajorek E, Bazaldua O, Trevino J, Albright T, Wright Frank, et al. Correlates of Medication Knowledge and Adherence: Finding From the Residency Research Network of South Texas. Fam Med. 2005; 379 Suppl 10: 712-8.
Yin, T., Miyata, T. Warfarin dose and the pharmacogenomic of CYP2C9 and VKORC1- Rational and Perspective.Thromb Res. 2007; 120 Suppl 1:1-10.
Yoshizawa M. Hayashi H, tashiro Y, Sakawa s, Moriwaki H, Akimoto T, Doi O, Kimura m,et al .of VIKORC1-1639 DNA polymorphisme, body weight, age, and serumalbumin alterations on warfarin response in japanese patiens. Thromb Res. 2007;124 Suppl 2:161-6.
T Rusdiana. T Araki. T Nakamura. A Subarnas. Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population. Eur J Clin Pharmacol. 2013; 69 Suppl 3:395-405.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.